norm: quince therapeuticsManufacturing · USno LEI · CIK 0001662774Max severity: Low

Canonical registry

Quince Therapeutics, Inc.

ent_019e3dfc0ea0de28683189782b2aa1a7

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Quince Therapeutics, Inc.
Normalized: quince therapeutics— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: 0001662774
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2026-04-10
Quince Therapeutics, Inc. (CIK 0001662774) filed its annual Form 10-K for the fiscal year ended December 31, 2025, on April 10, 2026. The filing covers Item 1C Cybersecurity but the full cybersecurity narrative was not included in the provided document excerpt. No specific cyber incident details were disclosed in the available text.